8-KOther Events

GILEAD SCIENCES, INC. 8-K Report (Apr 23, 2003)

Filed April 23, 2003For Securities:GILD

Summary

Gilead Sciences, Inc. (GILD) filed a Form 8-K on April 23, 2003, to report its earnings for the quarter ended March 31, 2003, via an accompanying press release (Exhibit 99.1). The filing primarily serves as a disclosure mechanism for these financial results. Management emphasized the use of non-GAAP financial measures, explaining that these are presented to provide investors with a clearer view of operating trends by excluding an unusual, infrequent in-process research and development charge related to an acquisition. The company highlighted that this non-GAAP presentation is intended to offer crucial insights into the core business's performance, allowing for a better understanding of underlying operational trends independent of the impact of this specific acquisition-related charge. Investors should refer to the press release for detailed financial figures and the specific nature of the non-GAAP adjustments.

Key Highlights

  • 1Gilead Sciences, Inc. announced its first-quarter 2003 earnings on April 23, 2003.
  • 2The earnings announcement was made via a press release filed as Exhibit 99.1 to the 8-K.
  • 3The company utilized non-GAAP financial measures in its earnings release.
  • 4Management believes non-GAAP measures provide better insight into core operating results and trends.
  • 5An in-process research and development (IPRD) charge related to an acquisition was the primary item excluded from GAAP.
  • 6The IPRD charge is described as unusual due to its nature, size, and infrequency.
  • 7The CFO, John F. Milligan, signed the report.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly disclose Gilead Sciences, Inc.'s earnings results for the quarter ended March 31, 2003, through an attached press release. It also serves to inform investors about the company's use of non-GAAP financial measures.

Gilead used non-GAAP financial measures because its management uses this information to monitor and evaluate operating results and trends, excluding certain items. They believe it provides investors with an important insight into the core business's performance, particularly by excluding an unusual and infrequent in-process R&D charge related to an acquisition.

The primary item excluded from GAAP to create the non-GAAP figures was an in-process research and development (IPRD) charge stemming from an acquisition. This charge was deemed unusual in nature, size, and infrequency.

The detailed financial results, including the specific non-GAAP adjustments and the performance metrics, are located in the press release filed as Exhibit 99.1 to this 8-K report.